News About: Pharm. Industry
Hanmi top executives wholly to reshuffle.
The top 10 executives of Hanmi Pharmaceutical Inc. were reorganized as of Dec. 28 as positioning President Min Gyeong-yun to the vice chairman and Standing adviser Chang Ahn-soo to the president.
New president Chan...
Plavix unvoidable to face with influx of generics next year.A lot of local drug companies are going to launch many generic drugs of Plavix (clopidogrel), an anti-platelet drug supplied by Sanofi-Aventis and BMS Korea, next year to provok...
|
Consultant-turned marketing experts drive on in pharmaceutical industry
The pharmaceutical industry has long been considered a pharmacist's territory, especially in marketing. There were only one or two management consultants, engaged in the marketing activities.
These days, however, m...
Competition will likely get fierce over anti-alopecia market
As a growing number of Korean people have suffered from hair loss, the domestic anti-alopecia market is expected to grow further next year, market experts claim. Competition is also fierce among the makers of pharmace...
Government agencies grant patent transfer to Huons
The Korea Food and Drug Administration and Forest Government Information Agency said on December 27 that their jointly owned patent on garlic extract was transferred to Huons Co., a local Korean drugmaker, on an exclu...
New reimbursement regulations face backlash
The government's plan to set up new regulations aiming to cut prices of pharmaceutical products and control soaring health insurance expenditures has trigged a backlash from the domestic pharmaceutical industry.
Th...
Local drug industry to forecast a double digit growth next year.
The leading pharmaceutical companies had made their sales forecasts in double digit of growth in 2007 following this year too with expectation for the sales targets of 2006 in double digit growth to achieve without di...
Novartis Korea was nominated as a full member nation for ICRO
Novartis head office has nominated Novartis Korea as a full member unit for the ICRO (International Clinical Research Operations) of Novartis and decided to expand R&D investment for clinical research works of anti-ca...
Who will take job as KPMA leader?
Considerable interest in selecting the next chairman of the Korea Pharmaceutical Manufacturers Association (KPMA), as the term of incumbent Chairman Huh Il-seob, chairman of Green Cross Corporation, ends in February n...
Anti-cancer drug, Genexol sold at over 10 billion won.
Genexol (paclitaxel), an anti-cancer drug, was developed by Samyang and distributed by CJ, now reaching its sales to 10 billion won at the early of Dec., which may achieve 11 billion won up the end of this year.
...
